The scientist’s investigation covers issues in Internal medicine, Endocrinology, Cardiology, Heart failure and Myocardial infarction. Many of his studies involve connections with topics such as Superoxide and Internal medicine. Cardiology is closely attributed to Pharmacotherapy in his research.
Johann Bauersachs has included themes like Cardiogenic shock, Heart disease and Intensive care medicine in his Heart failure study. His work in Myocardial infarction tackles topics such as Inflammation which are related to areas like Infarction. The various areas that Johann Bauersachs examines in his Nitric oxide study include Biochemistry and Bradykinin.
His main research concerns Internal medicine, Cardiology, Heart failure, Endocrinology and Myocardial infarction. He performs multidisciplinary studies into Internal medicine and In patient in his work. Cardiology is a component of his Cardiogenic shock, Cardiomyopathy, Atrial fibrillation, Sudden cardiac death and Ventricle studies.
His Heart failure study combines topics from a wide range of disciplines, such as Heart disease, Disease, Clinical trial and Intensive care medicine. His Endocrinology research is multidisciplinary, incorporating elements of Platelet activation and Platelet. His biological study focuses on Ventricular remodeling.
Johann Bauersachs mainly investigates Internal medicine, Cardiology, Heart failure, Ejection fraction and Myocardial infarction. Johann Bauersachs conducts interdisciplinary study in the fields of Internal medicine and In patient through his works. Many of his studies on Cardiology apply to Extracorporeal membrane oxygenation as well.
Johann Bauersachs works mostly in the field of Heart failure, limiting it down to concerns involving Intensive care medicine and, occasionally, MEDLINE. Ejection fraction and Heart rate are commonly linked in his work. Johann Bauersachs combines subjects such as Inflammation and Cancer research with his study of Myocardial infarction.
Johann Bauersachs mostly deals with Internal medicine, Cardiology, Heart failure, Ejection fraction and Myocardial infarction. He undertakes multidisciplinary investigations into Internal medicine and In patient in his work. His Cardiology study frequently draws connections between adjacent fields such as Extracorporeal membrane oxygenation.
Johann Bauersachs does research in Heart failure, focusing on Heart failure with preserved ejection fraction specifically. His work in Ejection fraction addresses subjects such as Canagliflozin, which are connected to disciplines such as Liraglutide and Dipeptidyl peptidase-4 inhibitor. His Myocardial infarction research incorporates elements of Inflammation, Translational research, Cancer research and Fibrosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon.
European Heart Journal (2013)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno.
European Journal of Heart Failure (2016)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum;Carina Gross;Jan Fiedler;Thomas Fischer.
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet;Holger Thiele;Emanuele Barbato;Olivier Barthélémy.
European Heart Journal (2021)
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
Christian Templin;Jelena R. Ghadri;Johanna Diekmann;L. Christian Napp.
The New England Journal of Medicine (2015)
MicroRNAs in the Human Heart A Clue to Fetal Gene Reprogramming in Heart Failure
Thomas Thum;Paolo Galuppo;Christian Wolf;Jan Fiedler.
2021 ESC/EACTS Guidelines for the management of valvular heart disease.
Alec Vahanian;Friedhelm Beyersdorf;Fabien Praz;Milan Milojevic.
European Heart Journal (2021)
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology
Petar M Seferovic;Piotr Ponikowski;Stefan D Anker;Johann Bauersachs.
European Journal of Heart Failure (2019)
Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production.
Johann Bauersachs;Anne Bouloumié;Daniela Fraccarollo;Kai Hu.
Nitric Oxide Attenuates the Release of Endothelium-Derived Hyperpolarizing Factor
Johann Bauersachs;Ru¨diger Popp;Markus Hecker;Edith Sauer.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: